Page last updated: 2024-08-25

losoxantrone and Prostatic Neoplasms

losoxantrone has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Finizio, M; Huan, SD; Natale, RB; Roberts, JD; Sartiano, GP; Stella, PJ; Stewart, DJ; Symes, AL	1
Beggiolin, G; Capranico, G; Carenini, N; Dal Bo, L; Facchinetti, F; Guano, F; Menta, E; Palumbo, M; Pavesi, R; Pezzoni, G; Polizzi, D; Pratesi, G; Richter, S; Sissi, C; Spinelli, S; Supino, R; Torriani, D; Tortoreto, M; Zunino, F	1

Trials

1 trial(s) available for losoxantrone and Prostatic Neoplasms

Article	Year
A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:4 Topics: Aged; Aged, 80 and over; Anorexia; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Diarrhea; Drug Resistance, Neoplasm; Follow-Up Studies; Heart Ventricles; Hematologic Diseases; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Pyrazolones; Stomatitis; Survival Analysis; Vomiting	2000

Article

Year

A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:4

Topics: Aged; Aged, 80 and over; Anorexia; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Diarrhea; Drug Resistance, Neoplasm; Follow-Up Studies; Heart Ventricles; Hematologic Diseases; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Pyrazolones; Stomatitis; Survival Analysis; Vomiting

2000

Other Studies

1 other study(ies) available for losoxantrone and Prostatic Neoplasms

Article	Year
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts. Oncology, 2001, Volume: 61, Issue:3 Topics: Adenocarcinoma; Animals; Anthraquinones; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Cell Division; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Ethanolamines; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Intercalating Agents; Male; Mice; Mice, Nude; Molecular Structure; Neoplasm Proteins; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Pyrazolones; Remission Induction; Xenograft Model Antitumor Assays	2001

Article

Year

A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.

Oncology, 2001, Volume: 61, Issue:3

Topics: Adenocarcinoma; Animals; Anthraquinones; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Cell Division; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Ethanolamines; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Intercalating Agents; Male; Mice; Mice, Nude; Molecular Structure; Neoplasm Proteins; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Pyrazolones; Remission Induction; Xenograft Model Antitumor Assays

2001